Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour
Primary Purpose
Anesthesia, Epidural, Opioid, Labor Pain
Status
Unknown status
Phase
Phase 4
Locations
Poland
Study Type
Interventional
Intervention
Fentanyl
Sufentanil
Sponsored by
About this trial
This is an interventional treatment trial for Anesthesia, Epidural
Eligibility Criteria
Inclusion Criteria:
- parturient in labour without cervical dilation and regular uterine contractions
Exclusion Criteria:
- no consent
- known allergy to administered opioid
- contraindications to epidural analgesia
- coagulopathies including platelet count of less than 100,000
- spine surgery in past
Sites / Locations
- Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka, WUMRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
No Intervention
Arm Label
Fentanyl
Sufentanyl
Control
Arm Description
100mcg Fentanyl administered into epidural space during regular contractions before cervical dilation
10mcg sufentanyl administered into the epidural space during regular contractions before cervical dilation
No epidural analgesia
Outcomes
Primary Outcome Measures
Pain intensity according to Numerical Rating Scale (NRS)
till 4cm cervical dilation in primigravida or 3cm multiparous
Secondary Outcome Measures
Fetal heart rate
till 4cm cervical dilation in primigravida or 3cm multiparous
Blood pressure parturient
till 4cm cervical dilation in primigravida or 3cm multiparous
Heart rate of parturient
till 4cm cervical dilation in primigravida or 3cm multiparous
Full Information
NCT ID
NCT03344042
First Posted
August 16, 2017
Last Updated
December 5, 2018
Sponsor
Medical University of Warsaw
1. Study Identification
Unique Protocol Identification Number
NCT03344042
Brief Title
Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour
Official Title
Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour
Study Type
Interventional
2. Study Status
Record Verification Date
December 2018
Overall Recruitment Status
Unknown status
Study Start Date
December 1, 2017 (Actual)
Primary Completion Date
December 20, 2018 (Anticipated)
Study Completion Date
December 20, 2018 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Warsaw
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Epidural anesthesia is used to relieve labour pain which helps reduce labour stress, increase comfort and improve cooperation with medical personnel. Administering opioid into the epidural space before cervical dilation of 4cm in the primigravida or 3cm in the multiparous can effectively reduce the pain levels with no effect on the labour progress. The aim of the study is to compare different opioids administered in this early labour stage.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anesthesia, Epidural, Opioid, Labor Pain
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Masking Description
Participant not aware of opioid administered
Allocation
Randomized
Enrollment
300 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Fentanyl
Arm Type
Active Comparator
Arm Description
100mcg Fentanyl administered into epidural space during regular contractions before cervical dilation
Arm Title
Sufentanyl
Arm Type
Active Comparator
Arm Description
10mcg sufentanyl administered into the epidural space during regular contractions before cervical dilation
Arm Title
Control
Arm Type
No Intervention
Arm Description
No epidural analgesia
Intervention Type
Drug
Intervention Name(s)
Fentanyl
Intervention Description
100mcg Fentanyl
Intervention Type
Drug
Intervention Name(s)
Sufentanil
Intervention Description
10mcg sufentanil
Primary Outcome Measure Information:
Title
Pain intensity according to Numerical Rating Scale (NRS)
Description
till 4cm cervical dilation in primigravida or 3cm multiparous
Time Frame
up to 24 hours
Secondary Outcome Measure Information:
Title
Fetal heart rate
Description
till 4cm cervical dilation in primigravida or 3cm multiparous
Time Frame
up to 24 hours
Title
Blood pressure parturient
Description
till 4cm cervical dilation in primigravida or 3cm multiparous
Time Frame
up to 24 hours
Title
Heart rate of parturient
Description
till 4cm cervical dilation in primigravida or 3cm multiparous
Time Frame
up to 24 hours
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
parturient in labour without cervical dilation and regular uterine contractions
Exclusion Criteria:
no consent
known allergy to administered opioid
contraindications to epidural analgesia
coagulopathies including platelet count of less than 100,000
spine surgery in past
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jan Bilawicz, MD
Phone
0048225830381
Email
bilawicz@wp.pl
Facility Information:
Facility Name
Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka, WUM
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
02-015
Country
Poland
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jan Bilawicz, MD
Phone
0048 22 583 03 81
Email
bilawicz@wp.pl
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour
We'll reach out to this number within 24 hrs